Waystar Holding Corp. (WAY)
Healthcare
- Fundamental
- 3
- Sentiment
- 4
- Technical
- 4
Buy limit 22.70 on a retest of the 22.65-22.75 support shelf; short-term trend and liquidity are supportive, the structure stop sits at 21.46 below the 3-session base, and targets at 25.30 / 27.25 yield 2.10 R/R to target1.
Company overview
Waystar Holding Corp. develops a cloud-based software platform for financial transactions in the healthcare industry. The platform offers functionalities like billing support, claims management, and analytics. Established in 2017, the company is headquartered in Lehi, Utah.
Fundamental
fairWaystar exhibits strong growth and profitability, but high leverage and valuation limit short-term upside.
Waystar is growing quickly with software-like margins and strong cash generation (FY2025 revenue $1.099B; gross margin ~68%; operating cash flow ~$310M). The trade-off is valuation and leverage: ~40x FY2025 GAAP earnings and ~3.1x net debt/Adjusted EBITDA, plus ongoing regulatory and cybersecurity risks disclosed in the 10-K. Overall: good business quality, but not a clear “cheap + low-risk” setup → score 3.
Sentiment
goodMedia coverage is net bullish post-earnings, with an upcoming Investor Day as a potential catalyst.
Setup is driven by the announced 2026-08-25 Investor Day (analyst-day style) following the 2026-07-29 Q2 results release and CFO appointment; last ~14d media tone is net bullish but the 30–90d sentiment delta is indeterminate (baseline sample <3). Red-Flag Screen clean (only law-firm solicitation noise; no regulator-confirmed investigations).
Technical
goodThe stock is in a short-term uptrend, with a pullback to support offering a potential entry point.
Short-term structure is bullish and liquid, with price above the 20/50-day and EMA9/21 stack plus ADX above 40, but the flat MACD histogram and sub-200-day position keep this at pullback quality rather than full breakout quality.
You’re looking at 2026-08-06 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.